160 related articles for article (PubMed ID: 22069274)
21. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
Hummel M; Durinovic-Bello I; Ziegler AG
J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
23. Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients 1miR-146.
Yang M; Ye L; Wang B; Gao J; Liu R; Hong J; Wang W; Gu W; Ning G
J Diabetes; 2015 Mar; 7(2):158-65. PubMed ID: 24796653
[TBL] [Abstract][Full Text] [Related]
24. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
[TBL] [Abstract][Full Text] [Related]
25. Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children.
Wahlberg J; Fredriksson J; Nikolic E; Vaarala O; Ludvigsson J;
Pediatr Diabetes; 2005 Dec; 6(4):199-205. PubMed ID: 16390388
[TBL] [Abstract][Full Text] [Related]
26. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
[TBL] [Abstract][Full Text] [Related]
27. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
28. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
[TBL] [Abstract][Full Text] [Related]
29. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
[TBL] [Abstract][Full Text] [Related]
30. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
Yang L; Zhou ZG; Huang G; Yan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
[TBL] [Abstract][Full Text] [Related]
31. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
32. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.
Pietropaolo M; Barinas-Mitchell E; Pietropaolo SL; Kuller LH; Trucco M
Diabetes; 2000 Jan; 49(1):32-8. PubMed ID: 10615947
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes.
Salas-Pérez F; Codner E; Valencia E; Pizarro C; Carrasco E; Pérez-Bravo F
Immunobiology; 2013 May; 218(5):733-7. PubMed ID: 22999472
[TBL] [Abstract][Full Text] [Related]
34. Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2β, and GAD65.
Abuhatzira L; Xu H; Tahhan G; Boulougoura A; Schäffer AA; Notkins AL
FASEB J; 2015 Oct; 29(10):4374-83. PubMed ID: 26148972
[TBL] [Abstract][Full Text] [Related]
35. Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).
Waugh K; Snell-Bergeon J; Michels A; Dong F; Steck AK; Frohnert BI; Norris JM; Rewers M
PLoS One; 2017; 12(4):e0174840. PubMed ID: 28380011
[TBL] [Abstract][Full Text] [Related]
36. [Expression of miR-22 and miR-150 in type 1 diabetes mellitus: Possible relationship with autoimmunity and clinical characteristics].
Estrella S; Garcia-Diaz DF; Codner E; Camacho-Guillén P; Pérez-Bravo F
Med Clin (Barc); 2016 Sep; 147(6):245-7. PubMed ID: 27377214
[TBL] [Abstract][Full Text] [Related]
37. Islet autoimmunity status in Asians with young-onset diabetes (12-40 years): association with clinical characteristics, beta cell function and cardio-metabolic risk factors.
Thai AC; Mohan V; Khalid BA; Cockram CS; Pan CY; Zimmet P; Yeo JP;
Diabetes Res Clin Pract; 2008 May; 80(2):224-30. PubMed ID: 18207602
[TBL] [Abstract][Full Text] [Related]
38. Subtyping of Type 1 Diabetes as Classified by Anti-GAD Antibody, IgE Levels, and Tyrosine kinase 2 (TYK2) Promoter Variant in the Japanese.
Mine K; Hirakawa K; Kondo S; Minami M; Okada A; Tsutsu N; Yokogawa Y; Hibio Y; Kojima F; Fujimoto S; Kurisaki H; Anzai K; Yoshikai Y; Nagafuchi S;
EBioMedicine; 2017 Sep; 23():46-51. PubMed ID: 28826655
[TBL] [Abstract][Full Text] [Related]
39. Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes.
de Jong VM; van der Slik AR; Laban S; van 't Slot R; Koeleman BP; Zaldumbide A; Roep BO
Genes Immun; 2016 Sep; 17(6):342-8. PubMed ID: 27467285
[TBL] [Abstract][Full Text] [Related]
40. Impact of islet autoimmunity on the progressive β-cell functional decline in type 2 diabetes.
Brooks-Worrell BM; Boyko EJ; Palmer JP
Diabetes Care; 2014 Dec; 37(12):3286-93. PubMed ID: 25239783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
